🦊/Investors

Sonder Capital β€” Full Portfolio

28 tracked investments Β· listed companies and verified rows first

PROCEPT BioRobotics Corpprocept-biorobotics.comNASDAQ: PRCTAug 2014

PROCEPT BioRobotics develops robotic-assisted surgical technology for men's health, focused on treating benign prostatic hyperplasia (BPH).

HealthtechMedical DevicesRoboticsRedwood City, US

Nikolai Aljuri, Ph.D.(Executive Officer, Director)Larry L. Wood(President, Chief Executive Officer & Director)Kevin Waters(EVP, Chief Financial Officer)inAlaleh Nouri(EVP, Chief Legal Officer & Corporate Secretary)in

BoardColby Wood(Director)

Board seatFred MollΒ· per SEC Form D

Co-investorsSonder Futures

Neptune Medicalneptunemedical.cominβœ“ verified

Neptune Medical is a medical device company developing GI endoscopy products based on its Dynamic Rigidization technology, including the FDA-cleared Pathfinder endoscope and the Triton robotic endoscopy system for colon navigation.

HealthtechMedical DevicesRoboticsSilicon Valley, US

Alex Tilson(Founder & CEO)in

Co-investorsInCube VenturesMighty CapitalShangBay Capital LLC

Reflexionmedicalreflexion.comin𝕏Apr 2016

RefleXion Medical develops SCINTIX autonomous radiotherapy, an external beam theranostic oncology platform that uses biological signals from radiopharmaceutical-labeled cancer cells to deliver real-time, motion-managed radiation to lung and bone tumors from primary or metastatic disease.

BiotechHealthtechMedical DevicesHayward, US

Samuel Mazin(Executive Officer, Director)inAkshay Nanduri(Executive Officer, Director)in

BoardJay Watkins(Director)in

Board seatFred MollΒ· per SEC Form D

Co-investorsAscension VenturesCatalio Capital Management, LPPfizer Venture InvestmentsSofinnova PartnersVenrockSonder Futures

Shockwave Medicalshockwavemedical.comin𝕏Dec 2018

Shockwave Medical develops intravascular lithotripsy (IVL) catheter systems used to treat calcified cardiovascular disease, marketed to interventional cardiologists and vascular specialists.

HardwareHealthtechMedical DevicesFremont, US

Daniel Hawkins(Executive Officer, Director)inTodd J. Brinton(Director)inIsaac(President)

BoardJay Watkins(Director)inAntoine Papiernik(Director)inFrederic H. Moll(Director)

Board seatTodd BrintonΒ· per SEC Form D

Co-investorsSofinnova PartnersVenrockSectoral Asset Management

Ciel Medicalcielmedical.cominFeb 2014

BiotechHealthtechSan Carlos, US

Mary Katherine Garrett(Executive Officer, Director)

BoardJay Watkins(Director)inDan Azagury(Director)inKate Garrett(Executive Officer, Director)inBeverly Huss(Director)

Co-investorsAstiaBand of Angels

Cordance Medicalcordancemedical.comin𝕏Nov 2025

Cordance Medical develops medical technology focused on diagnosing and treating patients with brain diseases, drawing on expertise from neurosurgery, neuroimaging, and biomedical engineering.

AI & Machine LearningBiotechDeep TechDigital HealthHealthtechMedical DevicesMountain View, US

Ryan Dittamore(CEO)in

Co-investorsAngel Physicians FundBeresford VenturesCreative Destruction Lab (CDL)Shanda GroupSmartGateVCR42

ForSight Roboticsforsightrobotics.comSeries B Β· Jun 2025 Β· $130M

ForSight Robotics develops the JASPER robotic surgery platform, combining robotics, advanced visualization, and AI-driven data analytics to assist ophthalmic surgeons in performing eye surgery.

AI & Machine LearningMedical DevicesRobotics

Co-investorsEclipse VenturesMithril Capital Management

Gauss Surgicalgausssurgical.com

HealthtechLos Altos, US

Siddarth Satish(Executive Officer, Director)Milton B. McColl(Executive Officer, Director)inRalph L. Arnheim III(Executive Officer)

BoardJay Watkins(Director)inMark Gonzalgo(Director)

Co-investorsCorewell Health VenturesPromus VenturesRex Health VenturesSUMMATION HEALTH VENTURES

Intuitive Surgicalintuitivesurgical.comin𝕏

Intuitive develops robotic-assisted surgical systems, including the da Vinci systems for minimally invasive surgery and the Ion system for bronchoscopy.

HealthtechMedical DevicesRobotics

Co-investorsKrillion VenturesMayfield FundPFC Family OfficeSt. Cloud Capital

Jupiterjupiter.coinOct 2025

Jupiter is a monetization platform for food content creators that facilitates brand partnerships with CPG companies, integrates with ad networks, and enables commerce through Instacart.

Creator EconomyE-commerceEnterprise SoftwareFoodTechMarketing TechMarketplacesNew York City, US

Chad Munroe(Co-founder / CEO)in

Co-investorsY CombinatorCathexis VenturesNFXSprint VcThe MBA Fund3one4 Capital+6 more

Jupiter Bioventuresjupiter.bioinOct 2025

Jupiter is a biotech company that discovers and develops new medicines across multiple therapeutic areas.

BiotechChapel Hill, US

Ned Sharpless(Co-founder & CEO)Leigh Delacy(Co-founder & Partner and COO)

Co-investorsEshelman Ventures, LLCMission Biocapital3one4 CapitalBEENEXTHummingbird VenturesLB Investment+2 more

Jupiterendojupiterendo.comin

Jupiter Endovascular develops the Vertex Pulmonary Embolectomy System, a catheter-based device with Transforming Fixation technology for treating pulmonary embolism and other cardiovascular conditions.

HealthtechMedical DevicesMenlo Park, US

Carl St. Bernard(Chief Executive Officer)inChuck Love(Chief Science Officer)in

Co-investorsMighty Capital

Mendaeramendaera.comin𝕏Series A Β· Aug 2023 Β· $24M

Mendaera builds robotic technology, including its Focalist System for robotic-guided access and procedures such as transplant biopsy, to help healthcare providers perform reproducible clinical procedures.

Digital HealthHealthtechMedical DevicesRoboticsSan Mateo, US

Josh DeFonzo(Founder)inJason Wilson(Founder)

Co-investorsThreshold VenturesFounders FundLux CapitalAverin CapitalFemHealth VenturesMana Ventures+1 more

Neuro42neuro42.aiinOct 2023

neuro42 develops a portable, FDA 510(k)-cleared MRI platform that brings neurological imaging directly to the patient rather than requiring transport to a facility.

Deep TechHealthtechMedical DevicesSan Francisco, US

Amit Vohra(Executive Officer, Director)inAbhita Batra(Executive Officer, Director)Shibu Gangadharan(Executive Officer)

BoardKrishna R. Bhupal(Director)Rahul Talwar(Director)

Co-investorsFrontier Path VCShangBay Capital LLC

Petal Surgicalpetal.healthSeries A Β· Oct 2025 Β· $10M

Petal is developing an incisionless surgery platform using Millisecond Pulse Histotripsy, a form of focused therapeutic ultrasound that breaks down targeted diseased tissue without incisions, heat, or trauma.

BiotechDeep TechHealthtechMedical DevicesRedwood City, US

Prash Chopra(Founding CEO & Director)Bowen Jiang(Co-founder)Nicholas Theodore(Co-founder & Director)Prashant Chopra(Executive Officer, Director, Promoter)

BoardFrederic Moll(Director)Rony Abovitz(Co-founding Advisor)

Co-investorsShangBay Capital LLCTSVCDolma VenturesK50 VenturesSonder Futures

Spirairspirair.comin

HealthtechSouth San Francisco, US

Ben Bishop(Executive Officer, Director)inJames Kintzing(Executive Officer, Director)

BoardRob Binney(Director)Carter Meyer(Director)Kate Garrett(Director)in

Co-investors1809 CapitalView Ventures

SquareMindsquaremind.comin

SquareMind develops Swan, an automated robot for full-body dermoscopy that maps the skin and pairs the scans with AI to support change detection.

AI & Machine LearningHealthtechMedical DevicesRoboticsParis, FR

Ali Khachlouf(CEO)inTanguy Serrat(CTO)in

Co-investorsEntrepreneur FirstTeampact.ventures

Vitestrovitestro.cominSeries A Β· Mar 2026 Β· $70M

Vitestro is a Netherlands-based medical robotics company that develops Aletta, an autonomous robotic phlebotomy device for diagnostic blood collection in hospitals and laboratories.

HealthtechMedical DevicesRoboticsNetherlands, NL

Toon Overbeeke(Co-founder & CEO)inBrian Joseph(Co-founder)in

Co-investorsNYBC VenturesIntervestInvest-NL

Other

Tracked investments with no reachable website or further public details β€” typically companies that wound down, renamed, or were absorbed.

Qool TherapeuticsAuris HealthBRIUS Technologies, Inc.BruxACephea Valve TechnologiesG I Windows IncPrimaNova LabSSIuLink Labs, Inc.XCath

Rows marked β€œSEC filing” are inferred from directors named on the company's SEC Form D β€” public regulatory data, not a portfolio list published by the firm.